Inovalon Holdings Inc.

BMO analyst Evan Seigerman calls the results less impactful given that Tirzapatide has already outperformed higher doses of Kagrisema in obesity trials.

Finally, pharmaceutical executive speaks with Jen Lampa, vice president of commercial strategy at Inovalon, on how real-time clinical and administrative data layers are reshaping clinical trial recruitment.

Lampa argues that feeding patient-specific diagnosis, medication, and medical history data into the enrollment process validates what patients self-report and reduces the burden placed on them during screening, building a sturdier foundation for the process overall.

She points to the FDA's June 2026 pilot program to shorten early-stage trial timelines and the growing acceptance of real-world data in trial design as evidence that recruitment models will need to adapt.

Big thank you to Roberta and Carol for making that happen.

Today's From the Vault Pick is my conversation with Nick Panay from about a year ago when he was the CMO at Inovalon.

And when we did this, Nick walks me through how he built, how he and his team built an AI first marketing organization from the ground up and how he got buy in from.

legal, from compliance, how he addressed his team's fears about AI taking their jobs, and how his team started using AI-generated podcasts to turn dense research into some content people would actually consume.

So since we recorded this...

Nick has actually moved on from Inovalon and is getting ready to get started on something new and exciting.

So keep an eye out for that.

But the playbook he laid out here, an AI first mindset, hiring for AI fluency and treating experimentation as a leadership mandate is arguably even more relevant today than when we first aired it about a year ago.

Big thank you to Roberta and Carol for making that happen.

Today's From the Vault Pick is my conversation with Nick Panay from about a year ago when he was the CMO at Inovalon.

And when we did this, Nick walks me through how he built, how he and his team built an AI first marketing organization from the ground up and how he got buy in from.

legal, from compliance, how he addressed his team's fears about AI taking their jobs, and how his team started using AI-generated podcasts to turn dense research into some content people would actually consume.

So since we recorded this...

Nick has actually moved on from Inovalon and is getting ready to get started on something new and exciting.

So keep an eye out for that.

But the playbook he laid out here, an AI first mindset, hiring for AI fluency and treating experimentation as a leadership mandate is arguably even more relevant today than when we first aired it about a year ago.

And we'll talk about that in a little bit.

But I went on to go to work at another company, Inovalon, which is a medical analytics company in Bowie, Maryland.

They had been just taken public.

They had just put 30% of the company on the market.

So I couldn't say anything about it.

My wife, my family, my friends, my priest, nobody knew what was going on with the case from 2015 until the announcement was made in May of 2019.

And so, you know, when I got fired from Inovalon, when I got fired from, you know, Infor, I couldn't say to anybody what was actually happening and why somebody might be targeting me in the market.

So this is all in the book.